Press Releases

Aeras Launches New Campaign to Protect Healthcare Workers from TB

Aeras Launches New Campaign to Protect Healthcare Workers from TB. ROCKVILLE, MD, USA, October 31, 2014 – Aeras launched TB Unmasked, a new campaign to raise awareness about the risks healthcare workers face on the front lines of the global tuberculosis (TB) epidemic, today at the Union World Conference on Lung Health in Barcelona.

PNAS Modeling Study Finds TB Vaccines for Adolescents/Adults Cost-Effective Even With Low Efficacy

ROCKVILLE, MD, USA, OCTOBER 8, 2014 — A new study published in the Proceedings of the National Academy of Sciences released this week finds that a tuberculosis (TB) vaccine could have an important impact in reducing TB-associated disease and death even if the vaccine had relatively low efficacy, provided that the vaccine was targeted for use in adolescents and adults rather than infants.

Large Trial Will Evaluate Vaccine’s Ability to Prevent Tuberculosis Disease

August 28, 2014 – Aeras today announced the initiation of a large, multi-country Phase IIb clinical trial to evaluate the ability of a novel vaccine candidate to prevent tuberculosis disease in adults.

Aeras Welcomes South African Pediatrician Marian Jacobs to its Board of Directors

May 12, 2014 - Ms. Marian Eslie Jacobs, a globally recognized expert in health research, health systems strengthening and child health, has accepted an appointment as the newest member of Aeras’s Board of Directors.

Daniel Reznikov Joins Aeras as CFO

May 5, 2014 - Aeras is pleased to have Daniel Reznikov join the organization as its Chief Financial Officer (CFO).